EUVIMEDEUVIMED entdecken
Crossref

Body dysmorphic disorder symptoms in patients with melasma

Yuan Zhu, Xiaohang Du, Sihao Shen, Xiuzu Song, Wenzhong Xiang iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Yuan Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Melanosis, Quality of Life, Severity of Illness Index, Body Dysmorphic Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Hangzhou Biomedical and Health Industry Development Support, Hangzhou Medical Key Discipline Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Body dysmorphic disorder (BDD) is a psychiatric condition characterized by extreme preoccupation with non‐existent or minor defects in appearance, disrupting daily functioning. Melasma is a common concern among BDD patients with dermatological conditions. This study aimed to estimate the incidence and characteristics of BDD in patients with melasma, and compare the psychological condition of patients and age‐ and sex‐matched healthy controls.

Methods

Patients with melasma and healthy controls were screened using the BDD Questionnaire (BDDQ), Self‐rating Anxiety Scale (SAS), and Self‐rating Depression Scale (SDS). A questionnaire was administered to collect demographic information and clinical characteristics. Standard statistical tests were conducted, such as descriptive analysis, chi‐square, and nonparametric tests. The level of statistical significance for all tests was set at a P < 0.05.

Results

Among the 470 patients with melasma included in the study, 53 were positive for BDDQ in the preliminary screening and were associated with a history of treatment, higher Melasma Area and Severity Index (MASI), and Melasma Quality of Life (MELASQoL) scores, and higher SAS and SDS scores. The positive rate of BDDQ ranged from 0.4%, using the most stringent criteria to assess melasma severity, to 11.3%, without using objective criteria. Compared to healthy controls, patients with melasma had a higher positive rate of BDDQ and higher SAS and SDS scores.

Conclusion

In patients with melasma who exaggerate the severity of the disease, psychiatric treatment and the patient‐physician relationship have a positive effect. This study assessed the positive rate of BDDQ in melasma and proposed the feasibility of psychiatric treatment for patients with melasma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanosisQuality of LifeSeverity of Illness IndexBody Dysmorphic DisordersHumansFemaleAdultMaleCase-Control StudiesMiddle AgedSurveys and QuestionnairesYoung AdultAnxietyDepressionIncidencePsychiatric Status Rating Scales

Autor:innen und Institutionen

  • Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
  • Department of Dermatology, Hangzhou Third People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.

ORCID-Profile: Wenzhong Xiang

Förderung

  • Hangzhou Biomedical and Health Industry Development Support
  • Hangzhou Medical Key Discipline Construction Project

Zitieren

APA

Zhu, Y., Du, X., Shen, S., Song, X., & Xiang, W. (2024). Body dysmorphic disorder symptoms in patients with melasma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17013

Vancouver

Zhu Y, Du X, Shen S, Song X, Xiang W. Body dysmorphic disorder symptoms in patients with melasma. International Journal of Dermatology. 2024. doi:10.1111/ijd.17013

BibTeX
@article{Zhu2024,
  author = {Zhu, Yuan and Du, Xiaohang and Shen, Sihao and Song, Xiuzu and Xiang, Wenzhong},
  title = {Body dysmorphic disorder symptoms in patients with melasma},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17013}
}
Kostenlos starten →